These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33023502)

  • 21. Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndrome.
    Weerts ZZRM; Vork L; Mujagic Z; Keszthelyi D; Hesselink MAM; Kruimel J; Leue C; Muris JWM; Jonkers DMAE; Masclee AAM
    Neurogastroenterol Motil; 2019 Aug; 31(8):e13629. PubMed ID: 31119844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional gastrointestinal disorders in inflammatory bowel disease: impact on quality of life and psychological status.
    Bryant RV; van Langenberg DR; Holtmann GJ; Andrews JM
    J Gastroenterol Hepatol; 2011 May; 26(5):916-23. PubMed ID: 21214889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life.
    Böhn L; Störsrud S; Törnblom H; Bengtsson U; Simrén M
    Am J Gastroenterol; 2013 May; 108(5):634-41. PubMed ID: 23644955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lower and Upper Gastrointestinal Symptoms Differ Between Individuals With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation.
    Shah ED; Almario CV; Spiegel BMR; Chey WD
    J Neurogastroenterol Motil; 2018 Apr; 24(2):299-306. PubMed ID: 29605985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastrointestinal-Specific symptom anxiety in patients with gastroparesis: Relationships to symptom severity and quality of life.
    Tanner SE; Burton Murray H; Brown TA; Malik Z; Parkman HP
    Neurogastroenterol Motil; 2023 May; 35(5):e14534. PubMed ID: 36740788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Novel Method to Classify and Subgroup Patients With IBS Based on Gastrointestinal Symptoms and Psychological Profiles.
    Black CJ; Yiannakou Y; Guthrie EA; West R; Houghton LA; Ford AC
    Am J Gastroenterol; 2021 Feb; 116(2):372-381. PubMed ID: 33110014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disorders of gut-brain interaction: Highly prevalent and burdensome yet under-taught within medical education.
    Simons J; Shajee U; Palsson O; Simren M; Sperber AD; Törnblom H; Whitehead W; Aziz I
    United European Gastroenterol J; 2022 Sep; 10(7):736-744. PubMed ID: 35781806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased psychological distress and somatization in patients with irritable bowel syndrome compared with functional diarrhea or functional constipation, based on Rome IV criteria.
    Shiha MG; Asghar Z; Thoufeeq M; Kurien M; Ball AJ; Rej A; Tai FWD; Afify S; Aziz I
    Neurogastroenterol Motil; 2021 Oct; 33(10):e14121. PubMed ID: 33719130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of Irritable Bowel Syndrome Features Over a 5-year Period.
    Clevers E; Tack J; Törnblom H; Ringström G; Luyckx K; Simrén M; Van Oudenhove L
    Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1244-1251.e1. PubMed ID: 29510214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abdominal Pain and Depression, Not Bowel Habits, Predict Health Care Utilization in Patients With Functional Bowel Disorders.
    Yu V; Ballou S; Hassan R; Singh P; Shah E; Rangan V; Iturrino J; Nee J; Lembo A
    Am J Gastroenterol; 2021 Aug; 116(8):1720-1726. PubMed ID: 34003175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of overlapping functional dyspepsia, belching disorders and functional heartburn on anxiety, depression and quality of life of Chinese patients with irritable bowel syndrome.
    Yao X; Yang Y; Zhang S; Shi Y; Zhang Q; Wang Y
    BMC Gastroenterol; 2020 Jul; 20(1):209. PubMed ID: 32631285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Symptom Profiles in Patients With Irritable Bowel Syndrome or Functional Abdominal Pain Compared With Healthy Controls.
    Varni JW; Shulman RJ; Self MM; Nurko S; Saps M; Saeed SA; Bendo CB; Patel AS; Dark CV; Zacur GM; Pohl JF;
    J Pediatr Gastroenterol Nutr; 2015 Sep; 61(3):323-9. PubMed ID: 26020482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global prevalence and burden of meal-related abdominal pain.
    Colomier E; Melchior C; Algera JP; Hreinsson JP; Störsrud S; Törnblom H; Van Oudenhove L; Palsson OS; Bangdiwala SI; Sperber AD; Tack J; Simrén M
    BMC Med; 2022 Feb; 20(1):71. PubMed ID: 35172840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What Is Unspecified Functional Bowel Disorder? A Commonly Seen, Rarely Recognized, and Poorly Understood Diagnosis.
    Ballou S; Rangan V; Eidelberg A; Proctor S; McHenry N; Nee J; Iturrino J; Lembo A; Singh P
    Am J Gastroenterol; 2023 Aug; 118(8):1402-1409. PubMed ID: 37053553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study.
    Vork L; Weerts ZZRM; Mujagic Z; Kruimel JW; Hesselink MAM; Muris JWM; Keszthelyi D; Jonkers DMAE; Masclee AAM
    Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 28804974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of gastrointestinal symptoms in different patient groups using the visual analogue scale for irritable bowel syndrome (VAS-IBS).
    Bengtsson M; Hammar O; Mandl T; Ohlsson B
    BMC Gastroenterol; 2011 Nov; 11():122. PubMed ID: 22073983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of life in irritable bowel syndrome: Exploring mediating factors through structural equation modelling.
    Trindade IA; Melchior C; Törnblom H; Simrén M
    J Psychosom Res; 2022 Aug; 159():110809. PubMed ID: 35649318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
    Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
    Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of functional bowel disorder patients: a cross-sectional survey using the Rome III criteria.
    Ford AC; Bercik P; Morgan DG; Bolino C; Pintos-Sanchez MI; Moayyedi P
    Aliment Pharmacol Ther; 2014 Feb; 39(3):312-21. PubMed ID: 24308816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of, and natural history among, individuals with Rome IV functional bowel disorders.
    Goodoory VC; Houghton LA; Black CJ; Ford AC
    Neurogastroenterol Motil; 2022 May; 34(5):e14268. PubMed ID: 34532930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.